During the recent session, FibroBiologics Inc (NASDAQ:FBLG)’s traded shares were 0.49 million, with the beta value of the company hitting -1.30. At the last check today, the stock’s price was $1.51, reflecting an intraday loss of -12.50% or -$0.22. The 52-week high for the FBLG share is $17.75, that puts it down -1075.5 from that peak though still a striking 28.48% gain since the share price plummeted to a 52-week low of $1.08. The company’s market capitalization is $55.12M, and the average intraday trading volume over the past 10 days was 0.62 million shares, and the average trade volume was 240.35K shares over the past three months.

FibroBiologics Inc (NASDAQ:FBLG) trade information

FibroBiologics Inc (FBLG) registered a -12.50% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -12.50% in intraday trading to $1.51, hitting a weekly high. The stock’s 5-day price performance is -5.39%, and it has moved by -19.48% in 30 days. Based on these gigs, the overall price performance for the year is -79.54%. The short interest in FibroBiologics Inc (NASDAQ:FBLG) is 1.8 million shares and it means that shorts have 9.43 day(s) to cover.

The consensus price target of analysts on Wall Street is $9, which implies an increase of 83.22% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $9 respectively. As a result, FBLG is trading at a discount of -496.03% off the target high and -496.03% off the low.

FBLG Dividends

FibroBiologics Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

FibroBiologics Inc (NASDAQ:FBLG)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of FibroBiologics Inc (FBLG) shares are iShares Russell 2000 ETF and Vanguard Extended Market Index Fund. Data provided on Nov 30, 2024 indicates that iShares Russell 2000 ETF owns about 680.9 shares. This amounts to just over 1.87 percent of the company’s overall shares, with a $1.02 million market value. The same data shows that the other fund manager holds slightly less at 407.67, or about 1.12% of the stock, which is worth about $0.61 million.